Journal article
Management of Duodenal Neuroendocrine Tumors: Surgical versus Endoscopic Mucosal Resection
Annals of surgical oncology, Vol.29, pp.75-84
09/13/2021
DOI: 10.1245/s10434-021-10774-9
PMCID: PMC8688294
PMID: 34515889
Abstract
Background: Management of duodenal neuroendocrine tumors (DNETs) is not standardized, with smaller lesions (< 1-2 cm) generally treated by endoscopic mucosal resection (EMR) and larger DNETs by surgical resection (SR). This study reviewed how patients were selected for treatment and compared outcomes.
Patients and methods: Patients with DNETs undergoing resection were identified through institutional databases, and clinicopathologic data recorded. χ2 and Wilcoxon tests compared variables. Survival was determined by Kaplan-Meier, and Cox regression tested association with survival.
Results: Among 104 patients, 64 underwent EMR and 40 had SR. Patients selected for SR had larger tumor size, younger age, and higher T, N, and M stage. There was no difference in progression-free (PFS) or overall survival (OS) between SR and EMR. In 1-2 cm DNETs, there was no difference in PFS between SR and EMR [median not reached (NR), P = 0.1]; however, longer OS was seen in SR (median NR versus 112 months, P = 0.03). In 1-2 cm DNETs, SR patients were more likely to be node-positive and younger. After adjustment for age, resection method did not correlate with survival. Comparison of surgically resected DNETs versus jejunoileal NETs revealed longer PFS (median NR versus 73 months, P < 0.001) and OS (median NR versus 119 months, P = 0.004) DISCUSSION: In 1-2 cm DNETs, there was no difference in survival between EMR and SR after adjustment for age. Recurrences could be salvaged, suggesting that EMR is a reasonable strategy. Compared with jejunoileal NETs, DNETs treated by SR had improved PFS and OS.
Keywords: Duodenal neuroendocrine tumors; Duodenum; Endoscopic mucosal resection; Endoscopy; Neuroendocrine; Surgery.
© 2021. Society of Surgical Oncology.
Details
- Title: Subtitle
- Management of Duodenal Neuroendocrine Tumors: Surgical versus Endoscopic Mucosal Resection
- Creators
- Catherine G Tran - University of IowaScott K Sherman - University of Iowa, SurgeryMohammed O Suraju - University of Iowa Hospitals and ClinicsApoorve NayyarHenning Gerke - University of Iowa, Internal MedicineRami G. El Abiad - University of Iowa, Internal MedicineChandrikha Chandrasekharan - University of Iowa, Internal MedicinePo Hien Ear - University of Iowa, SurgeryThomas M O’Dorisio - University of Iowa, Internal MedicineJoseph S Dillon - University of Iowa, Endocrinology and MetabolismAndrew M Bellizzi - University of Iowa, PathologyJames R Howe - University of Iowa, Surgery
- Resource Type
- Journal article
- Publication Details
- Annals of surgical oncology, Vol.29, pp.75-84
- DOI
- 10.1245/s10434-021-10774-9
- PMID
- 34515889
- PMCID
- PMC8688294
- NLM abbreviation
- Ann Surg Oncol
- ISSN
- 1068-9265
- eISSN
- 1534-4681
- Grant note
- DOI: 10.13039/100000054, name: National Cancer Institute, award: P50CA174521, T32CA078586, T32CA148062
- Language
- English
- Date published
- 09/13/2021
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Gastroenterology and Hepatology; Pathology; Surgery; Fraternal Order of Eagles Diabetes Research Center; Endocrinology and Metabolism; Internal Medicine
- Record Identifier
- 9984183985102771
Metrics
19 Record Views